North Carolina gene editing firm signs deal with Pfizer worth up to $1.35B

Press/Media

Period	11 Jan 2022

Media coverage

Title	North Carolina gene editing firm signs deal with Pfizer worth up to $1.35B
Media name/outlet	Triad Business Journal
Country/Territory	United States
Date	11/01/22
URL	https://www.bizjournals.com/triad/news/2022/01/11/beam-therapeutics-inks-deal-with-pfizer-worth-up-t.html?ana=RSS&s=article_search
Persons	David Liu